Panel: How AI/ML is Accelerating Drug Development

Session details:

AI is transforming biotech R&D—from target validation to translational insights—but turning potential into progress requires more than just powerful algorithms. This panel explores how leading companies are using AI to accelerate discovery, improve preclinical predictability, and optimize clinical design—while navigating regulatory and build-vs-buy decisions that define long-term success. 

• Smarter Discovery: AI-driven approaches to target ID, compound screening, and molecular design. 
• Preclinical Predictability: Leveraging models to forecast safety, efficacy, and translational outcomes.
• Clinical Trial Optimization: Enhancing patient selection, site strategy, and adaptive trial design with AI.
• Strategic Integration: Balancing in-house innovation with external AI partnerships to scale impact.
• Lab of the Future and Digital Tools